Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Nutrients|March 6, 2021
Temporal Development of Dyslipidemia and Nonalcoholic Fatty Liver Disease (NAFLD) in Syrian Hamsters Fed a High-Fat, High-Fructose, High-Cholesterol DietVictoria Svop Jensen, Christian Fledelius, Erik Max Wulff, et al.Journal of Lipid Research|March 5, 2004
Prediction of PPAR-alpha ligand-mediated physiological changes using gene expression profilesKlaus Stensgaard Frederiksen, Erik Max Wulff, Per Sauerberg, et al.European Journal of Pharmacology|October 13, 2009
Improved insulin sensitivity and islet function after PPARdelta activation in diabetic db/db miceMaria Sörhede Winzell, Erik Max Wulff, Grith Skytte Olsen, et al.European Journal of Pharmacology|September 2, 2008
Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-gamma) agonist balaglitazonePhilip J Larsen, Kirsten Lykkegaard, Leif K Larsen, et al.Diabetology & Metabolic Syndrome|February 8, 2018
Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague-Dawley ratsVictoria Svop Jensen, Henning Hvid, Jesper Damgaard, et al.British Journal of Pharmacology|January 27, 2011
PPARδ agonists have opposing effects on insulin resistance in high fat-fed rats and mice due to different metabolic responses in muscleJi-Ming Ye, Jennifer Tid-Ang, Nigel Turner, et al.Journal of Translational Medicine|February 18, 2021
Insulin treatment improves liver histopathology and decreases expression of inflammatory and fibrogenic genes in a hyperglycemic, dyslipidemic hamster model of NAFLDVictoria Svop Jensen, Christian Fledelius, Christina Zachodnik, et al.Nature Communications|July 29, 2020
Molecular engineering of safe and efficacious oral basal insulinFrantisek Hubálek, Hanne H F Refsgaard, Sanne Gram-Nielsen, et al.Pageof 1